共 134 条
[1]
Rowley JD(1973)A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and giemsa staining Nature 243 290-293
[2]
Quintás-Cardama A(2006)Chronic myeloid leukemia: diagnosis and treatment Mayo Clin Proc 81 973-988
[3]
Cortes JE(2002)Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study Blood 99 1928-1937
[4]
Talpaz M(2007)Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia Lancet Oncol 8 1018-1029
[5]
Apperley JF(2011)BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet Blood 118 1208-1215
[6]
Soverini S(2017)Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance Hematology 22 201-207
[7]
Hochhaus A(2017)hOCT1 gene expression predict for optimal response to imatinib in Tunisian patients with chronic myeloid leukemia Cancer Chemother Pharmacol 79 737-745
[8]
Nicolini FE(2004)Active transport of imatinib into and out of cells: implications for drug resistance Blood 104 3739-3745
[9]
Soltani I(2008)Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia Blood 112 2024-2027
[10]
Douzi K(2011)Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia Med Oncol 28 265-269